Canadian application, no grantCanada
Peptides which elicit cytotoxic t cellular immunity
CA 2301840 A1 · Owner: Norsk Hydro Asa · Inventors: Gjertsen, Marianne Klemp; Eriksen, Jon Amund; Gaudernack, Gustav
Overview
Drawings and full text
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Synthetic peptides of oncogene protein products which elicit cytotoxic T cellular immunity, for use in cancer vaccines and compositions for anti-cancer treatment.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed August 26, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended August 26, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by August 26, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledAugust 26, 1998
GrantedNo grant recorded
Term endedAugust 26, 2018
Patent numberCA 2301840 A1
Classification (IPC)C07K14/82 +2 more
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.